mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.33 |
1e-16 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
7e-14 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
9e-14 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.25 |
4e-13 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
-0.26 |
1e-12 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
2e-12 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.3 |
4e-12 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-11 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
5e-11 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
6e-11 |